No description

Candiolo Cancer Institute - Gastric

Researchers at the University of Torino, Italy, aim at identifying new molecular targets in gastric cancer.

We have produced an extensive experimental resource of PDXs from primary gastro-esophageal tumors, coupled with molecular annotation including HER2 (HercepTest ), MSI, EBV status and Targeted/Whole exome sequencing. This platform enables population-level discovery of genetic and functional vulnerabilities, which can be targeted in preclinical xenotrials.

The Candiolo Cancer Institute is a member of the EurOPDX Consortium. EurOPDX is supported by the European Union's Horizon 2020 research and innovation program under the grant agreement No. 731105 EDIReX

You are running an old browser version. We recommend updating your browser to its latest version.

More info